ArticleClinical and experimental immunology2016

Efficacy and safety of Gammaplex(®) 5% in children and adolescents with primary immunodeficiency diseases.

I R Melamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.